Provided by Tiger Trade Technology Pte. Ltd.

Ligand Pharmaceuticals

295.00
+1.740.59%
Pre-market: 299.354.35+1.47%08:17 EDT
Volume:318.88K
Turnover:92.72M
Market Cap:5.88B
PE:30.38
High:296.48
Open:290.41
Low:281.74
Close:293.26
52wk High:326.63
52wk Low:175.89
Shares:19.94M
Float Shares:19.35M
Volume Ratio:1.34
T/O Rate:1.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):9.71
EPS(LYR):6.13
ROE:21.96%
ROA:3.99%
PB:6.08
PE(LYR):48.12

Loading ...

Nov 01, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Aug 02, 2024

Major Issues Report

Form 8-K - Current report
Jul 17, 2024

Major Issues Report

Form 8-K - Current report
Jul 10, 2024

Major Issues Report

Form 8-K - Current report
Jul 09, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jul 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
Jun 18, 2024

Major Issues Report

Form 8-K - Current report
Jun 17, 2024

Major Issues Report

Form 8-K - Current report
May 30, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities